Submit an abstract by August 27 for the AACR Special Conference on Liquid Biopsy: From Discovery to Clinical Implementation (November 13-16, San Diego), chaired by Catherine Alix-Panabières, Luis A. Diaz, Jr., Maximilian Diehn, Y.M. Dennis Lo, and Klaus Pantel. Learn more: https://bit.ly/3Sqssfo #aacrLBx24
American Association for Cancer Research
Non-profit Organizations
Philadelphia, PA 62,654 followers
Leading Discoveries. Targeting Cures. Saving Lives.
About us
Founded in 1907, the American Association for Cancer Research (AACR) is the world’s first and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. AACR membership includes more than 54,000 laboratory, translational, and clinical researchers; population scientists; other health care professionals; and patient advocates residing in 130 countries and territories around the world. Presently, 32 percent of members live outside the United States and 22 percent of AACR’s international members are located in countries with emerging economies. The AACR marshals the full spectrum of expertise of the cancer community to accelerate progress in the prevention, diagnosis, and treatment of cancer by annually convening more than 30 conferences and educational workshops, the largest of which is the AACR Annual Meeting. In addition, the AACR publishes 10 prestigious, peer-reviewed scientific journals and a magazine for cancer survivors, patients, and their caregivers. The AACR funds meritorious research directly as well as in cooperation with numerous cancer organizations. As the Scientific Partner of Stand Up To Cancer, the AACR provides expert peer review, grants administration, and scientific oversight of team science and individual investigator grants in cancer research that have the potential for near-term patient benefit. The AACR actively communicates with legislators and other policymakers about the value of cancer research and related biomedical science in saving lives from cancer. For more information about the AACR, visit AACR.org.
- Website
-
https://aacr.org
External link for American Association for Cancer Research
- Industry
- Non-profit Organizations
- Company size
- 201-500 employees
- Headquarters
- Philadelphia, PA
- Type
- Nonprofit
- Founded
- 1907
- Specialties
- cancer research, research, Cancer Today Magazine, Cancer Discovery Journal, Cancer Epidemiology, Biomarkers & Prevention, Cancer Immunology Research, Clinical Cancer Research, Runners for Research, cancer, cancer prevention, immunology, Cancer Progress Report, and AACR
Locations
-
Primary
615 Chestnut Street
17th floor
Philadelphia, PA 19106, US
-
1425 K Street, NW, Suite 250
Washington, DC 20005, US
-
18 Tremont Street
Suite 703
Boston, MA 02108, US
Employees at American Association for Cancer Research
Updates
-
The AACR Scientific Achievement Awards Program recognizes scientific excellence across the full spectrum of cancer research by honoring scientists, clinicians, and physician-scientists who have made significant contributions to our understanding of the diagnosis, prevention, and treatment of cancer. Nominate a colleague by September 15: https://bit.ly/46ohnBB
-
-
Disparities researchers and cancer survivors discussed the persistent health inequities patients face during a recent AACR roundtable. Learn more and watch the full recording on the #AACRBlog: https://bit.ly/3A0o3tv
-
-
AACR Project GENIE®, a publicly accessible cancer registry of real-world clinico-genomic data, has released its 16th public dataset. The registry now contains more than 214,000 genomic samples from almost 185,000 patients. The combined data set now features 112 major cancer types, including data from approximately 27,000 patients with lung cancer, 18,500 patients with colorectal cancer, and 16,500 patients with breast cancer. Learn more: https://bit.ly/3WkJf4X #AACRGENIE
-
-
"An unparalleled learning experience in regulatory science. The fellowship provides case-based didactics with interactive sessions including FDA reviewers. Understanding the role and perspective of the FDA will be instrumental in future trial work and design." Matthew Hadfield, DO, discussed his experience as a participant in the FDA-AACR Oncology Educational Fellowship program, which provides early-career scientists and clinicians with an opportunity to learn more about drug development and the regulatory review process. Apply by August 1 to join the 2024-2025 class of fellows: https://bit.ly/3LGVeog #AACRSciencePolicy
-
-
Submit an abstract by August 5 for the AACR Special Conference on Tumor Immunology and Immunotherapy (October 18-21, Boston), chaired by Yvonne Y. Chen, Sergio Quezada, Robert D. Schreiber, and Fernando Vidal-Vanaclocha. Learn more: https://bit.ly/4ffuU2f #AACRtii24
-
-
Submit an abstract by August 26 for the AACR Conference on RNAs as Drivers, Targets, and Therapeutics in Cancer (November 14-17, Bellevue, Washington) chaired by Howard Y. Chang, Joshua T. Mendell, Anastasia Khvorova, and V. Narry Kim. https://bit.ly/46mm7Yr #aacrRNA24
-
-
On the #AACRBlog: Our quarterly review of FDA approvals highlights the first T-cell engager for a solid tumor and more. https://bit.ly/3A4q3AG
-
-
The new issue of Leading Discoveries is online now, featuring a discussion with AACR President Patricia M. Lorusso, DO, PhD (hc), and articles on the importance of collaborating in cancer research innovation and and how scientists can better effectively communicate with the public. Read these articles and others that highlight research-driven advances in cancer treatment and prevention. https://bit.ly/3WaZQYA
-
-
Register by August 5 to get the lowest rates for the AACR Special Conference on Advances in Pancreatic Cancer Research (September 15-18, Boston), chaired by Peter J. Allen, Stephanie K. Dougan, Tony Hollingsworth, and Alec C. Kimmelman. Learn more: https://bit.ly/4cXo0gG #AACRpan24
-